期刊文献+

甲状腺癌钠/碘转运蛋白及促甲状腺激素受体表达及相关性研究 被引量:4

Expression of sodium/iodide symporter and thyroid stimulating hormone receptor in thyroid
原文传递
导出
摘要 目的研究甲状腺癌钠/碘转运蛋白(NIS)和促甲状腺激素受体(TSHR)的表达特征及其相关性。方法收集正常甲状腺组织52例、结节性甲状腺肿58例和甲状腺癌56例,通过荧光定量分析和免疫组化法研究NIS和TSHR的表达。结果甲状腺癌NISmRNA和TSHRmRNA的表达显著低于正常甲状腺组织和结节性甲状腺肿(P〈0.001),正常甲状腺组织和结节性甲状腺肿NIS和TSHR的表达呈正相关(r=0.758和0.653,P=0.006和0.005),而在甲状腺癌中无显著相关性(r=0.389,P=0.136)。免疫组化结果表明甲状腺癌NIS阳性产物主要定位于细胞质,TSHR阳性产物定位于细胞质和细胞膜。甲状腺癌和结节性甲状腺肿NIS及TSHR蛋白表达显著高于正常甲状腺(P〈0.001);同正常甲状腺组织相比,甲状腺癌NIS及TSHRmRNA表达下降同时伴有细胞质蛋白表达升高的分别为45例和47例(80%,85%)。结论甲状腺癌NIS和TSHR表达具有非相关性以及在转录和翻译水平上具有矛盾性,NIS蛋白非功能定位于细胞质,因而不能发挥正常的运输及聚碘功能。 Objective To investigate the expression of sodimn/iodide symporter (NIS) and thyroid stimulating hormone receptor (TSHR)in human thyroid carcinoma. Methods Samples of normal thyroid tissues (52 cases), nodular goiters (58 cases) and thyroid carcinoma (56 cases) were collected to examine the expression of NIS and TSHR by quantitative fluorescence analysis and immunohistoehemistry. Results NIS and TSHR mRNA level were significantly lower in thyroid carcinoma than in normal thyroid tissues and nodular goiters (P 〈 0.001 ). In addition, there was a positive correlation between NIS and TSHR in normal thyroid tissues and nodular goiters ( r = 0. 758 and 0. 653 respectively, P = 0. 006 and 0. 005 respectively) , whereas there was no such correlation in thyroid carcinoma(r = 0. 389, P = 0. 136). Immunohistochemistry results showed NIS protein of thyroid cancer was mainly located in cytoplasm, and TSHR protein was mainly located in cytoplasm as well as cytomembrane. The expression of NIS and TSHR protein was markedly higher in thyroid carcinoma and nodular goiter than in normal thyroid tissues(P 〈 0. 001 ). Combined analysis of mRNA concentration and immunostaining scores showed that reduction of NIS and TSHR mRNA expression with increasement of intracellular protein was found in 80% (45/56) and 85% (47/56) of the samples in thyroid carcinomas when compared with normal tissues. Conclusions In thyroid carcinomas, there is expressed contradiction and non-correlation between NIS and TSHR expression. NIS protein is mainly located in cytoplasm and lack the ability of iodine transportation and absorption.
出处 《中华内分泌外科杂志》 CAS 2012年第1期7-10,共4页 Chinese Journal of Endocrine Surgery
基金 甘肃省科技支撑计划资助项目(0804NKCA087)
关键词 甲状腺癌 钠/碘转运蛋白 促甲状腺激素受体 荧光定量分析 免疫组织化学 Thyroid cancer Sodium/iodide symporter Thyroid stimulating hormone receptor Quantitative fluorescence analysis Immunohistochemistry
  • 相关文献

参考文献8

  • 1Yu GP, Li JC, Branovan D, et al. Thyroid cancer incidence and surival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups[ J]. Thyroid,2010,20 (5) : 465-473.
  • 2Sodre AK, Ruhio IG, Galrao AL, et al. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining [ J]. J Clin Endocrinol Metab ,2008,93 (10) :4141-4145.
  • 3Kawbr osini G, Adida C, Altieri DC. A novel antiapoptosis by survivin, predicts shorter survival rates in colorectal cancer [ J ]. Cancer Res, 1998,58 (22) : 5071-5075.
  • 4李志刚,邓敬兰,汪静,侯英萍.放射性^(131)I照射与分化型甲状腺癌细胞摄碘(^(125)I)率关系的实验研究[J].现代肿瘤医学,2006,14(6):667-669. 被引量:6
  • 5Tanaka K, Otsuki T, Sonoo H, et al. Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT- PCR[ J ]. Eur J Endocrinol,2000,142 (4) : 340-346.
  • 6Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, et al. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors[J]. Am J Pathol,2004,165( 1 ) :25-34.
  • 7Wapnir IL, van de Rijn M, Nowels K, et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections[J]. J Clin Endocrinol Metab,2003,88(4) :1880-1888.
  • 8Smith VE, Read ML, Turnell AS, et al. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer [ J]. J Cell Sci ,2009,122 ( 18 ) : 3393-3402.

二级参考文献12

  • 1Czepczynski R,Ziemnicka K,Baczyk M,et al.Fractionated dosage of radioiodine for the ablation of differentiated thyroid carcinoma[J].Thyroid,2005,15 (11):1261 ~ 1265.
  • 2Petrich T,Helmeke HJ,Meyer GJ,et al.Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter [J].Eur J Nucl Med Mol Imaging,2002,29 (7):842 ~ 854.
  • 3Petrich T,Knapp WH,Potter E.Functional activity of human sodium/iodide symporter in tumor cell lines[J].Nuklearmedizin,2003,42(1):15 ~18.
  • 4Rouxel A,Hejblum G,Bernier MO,et al.Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas [J].J Clin Endocrinol Metab,2004,89(11):5362 ~ 5368.
  • 5Sherman SI.Thyroid carcinoma[J].Lancet,2003,361:501 ~511.
  • 6Weiss SJ,Philp NJ,Grollman EF.Iodide transport in a continuous line of cultured cells from rats thyroid[J].Endocrinology,1984,114:1090~1098.
  • 7Simon D,Koehrle J,Reiners C,et al.Redifferentiation therapy with retinoids:the rapeutic option for advanced follicular and papillary thyroid carcinoma[J].World J Surg,1998,22:569 ~574.
  • 8Mclver B,Hay ID,Giuffrida DF,et al.Anaplastic thyroid carcinoma:a 50-yearexperience at a single institution [J].Surgery,2001,130:1028~1034.
  • 9Simon D,Korber C,Krausch M,et al.Clinical impact of retinods in redifferentiation of advanced thyroid cancer:final results of a pilot study[J].Eur J Nucl Med,2002,29:775 ~782.
  • 10Wang W,Macapinlac H,Larson SM,et al.18F-2-fluoro-2-deoxy-D-glucose positrin emission tomography localizes residual thyroid cancer in patients with negative diagnotic 131I whole body scans elevated serum thyroglobulin leves [J].J Clin Endocrinol Metab,1999,84:2291 ~2302.

共引文献5

同被引文献60

  • 1程维刚,殷德涛,卢秀波,邱新光.分化型甲状腺癌组织中促甲状腺激素受体的表达[J].郑州大学学报(医学版),2005,40(4):626-627. 被引量:7
  • 2Peli M,Capalbo E,Lovisatti M,et al. Ultrasound guided fine-needle aspiration biopsy of thyroid nodules : Guidelines andrecommendations vs clinical practice : a 12-month study of 89patients [J]. J Ultrasound,2012,15(2) : 102-107.
  • 3Dal ML, Bosetti C,La VC ,et al. Risk factors for thyroid can-cer: an epidemiological review focused on nutritional factors [J].Cancer Causes Control,2009,20 (1): 75-86.
  • 4Guan H,Ji M,Bao R,et al. Association of high iodine intakewith the T1799A BRAF mutation in papillary thyroid cancer [J].J Clin Endocrinol Metab,2009,94(5) : 1612-1617.
  • 5American Thyroid Association (ATA)Guidelines Taskforce onThyroid Nodules and Differentiated Thyroid Cancer,CooperDS,Doherty GM, et al. Revised American Thyroid Associationmanagement guidelines for patients with thyroid nodules anddifferentiated thyroid cancer [J]. Thyroid,2009,19 (11):1167-1214.
  • 6Laurberg P, Bulow PI, Knudsen N,et al. Environmental io-dine intake affects the type of nonmalignant thyroid disease [J].Thyroid,2001,11(5): 457-469.
  • 7Rivkees SA,Mazzaferri EL,Verburg FA,et al.The treatment of differentiated thyroid cancer in children:emphasis on surgical approach and radioactive iodine therapy[J].Endocr Rev,2011,32(6):798-826.
  • 8Bresner L,Banach R,Rodin G,et al.Cancer-related worry in Canadian thyroid cancer survivors[J].J Clin Endocrinol Metab,2015,100(3):977-985.
  • 9Hatch M,Polyanskaya O,Mc Connell R,et al.Urinary Iodine and Goiter Prevalence in Belarus:experience of the Belarus-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl nuclear accident[J].Thyroid,2011,21(4):429-437.
  • 10Veiga LH,Neta G,Aschebrook-Kilfoy B,et al.Thyroid cancer incidence patterns in Sao Paulo,Brazil,and the U.S.SEER program,1997-2008[J].Thyroid,2013,23(6):748-757.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部